Page last updated: 2024-08-17

carbostyril and Migraine Disorders

carbostyril has been researched along with Migraine Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantor, GH; Chaturvedula, PV; Conway, CM; Davis, C; Denton, R; Dubowchik, GM; Keavy, D; Macci, R; Macor, JE; Mathias, N; Mercer, SE; Moench, P; Pin, SS; Schartman, R; Signor, L; Thalody, G; Whiterock, V; Xu, C1
Conway, CM; Dalterio, RA; Degnan, AP; Dubowchik, GM; Macci, R; Macor, JE; Mercer, SE; Schartman, R; Xu, C1
LaPorta, LD1

Other Studies

3 other study(ies) available for carbostyril and Migraine Disorders

ArticleYear
Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migr
    Bioorganic & medicinal chemistry letters, 2013, Jun-01, Volume: 23, Issue:11

    Topics: Administration, Intranasal; Amides; Animals; Caco-2 Cells; Calcitonin Gene-Related Peptide Receptor Antagonists; Callithrix; Coronary Vessels; Drug Evaluation, Preclinical; Face; Humans; Indazoles; Migraine Disorders; Quinolones; Rabbits; Rats; Receptors, Calcitonin Gene-Related Peptide; Respiratory Mucosa

2013
Carbamates as potent calcitonin gene-related peptide antagonists with improved solution stability.
    Bioorganic & medicinal chemistry letters, 2009, Jul-01, Volume: 19, Issue:13

    Topics: Calcitonin Gene-Related Peptide Receptor Antagonists; Carbamates; Drug Stability; Humans; Indazoles; Migraine Disorders; Quinazolinones; Quinolones; Receptors, Calcitonin Gene-Related Peptide

2009
Relief from migraine headache with aripiprazole treatment.
    Headache, 2007, Volume: 47, Issue:6

    Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine Agents; Female; Humans; Migraine Disorders; Piperazines; Quinolones

2007